Showing results (41-50 of 163) with videos related to
Sort By:
Pageof 17
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 2, 2014
Accuracy of 2-hydroxyglutarate quantification by short-echo proton-MRS at 3 T: a phantom studyNicola Bertolino, Chiara Marchionni, Francesco Ghielmetti, et al.Oncotarget|August 8, 2012
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastomaMaria Carmela Speranza, Véronique Frattini, Federica Pisati, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|April 4, 2008
Radiation-induced glioblastoma in a medulloblastoma patient: a case report with molecular featuresMarco Gessi, Emanuela Maderna, Sara Guzzetti, et al.Neuro-Oncology|March 24, 2010
Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironmentSerena Pellegatta, Pietro Luigi Poliani, Elena Stucchi, et al.Stem Cells Translational Medicine|August 15, 2015
Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma PatientsSara Nava, Daniela Lisini, Simona Pogliani, et al.Neuro-Oncology|May 25, 2007
Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1Ettore Salsano, Laura Croci, Emanuela Maderna, et al.Cancers|December 9, 2023
Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic PerspectivesAlberto Picca, Giulio Sansone, Orazio Santo Santonocito, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2021
Anti-Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint InhibitorsAlberto Picca, Nefeli Valyraki, Cristina Birzu, et al.Journal of Neuro-Oncology|August 19, 2011
Expression profile of frizzled receptors in human medulloblastomasEttore Salsano, Rosina Paterra, Miriam Figus, et al.Plos One|March 29, 2014
Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecanDomenico Aquino, Anna Luisa Di Stefano, Alessandro Scotti, et al.Pageof 17